These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37543511)

  • 1. Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism.
    Nakao H; Yokomoto-Umakoshi M; Nakatani K; Umakoshi H; Ogata M; Fukumoto T; Kaneko H; Iwahashi N; Fujita M; Ogasawara T; Matsuda Y; Sakamoto R; Izumi Y; Bamba T; Ogawa Y
    EBioMedicine; 2023 Sep; 95():104733. PubMed ID: 37543511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
    Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
    Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical hypercortisolism: a systematic review, meta-analysis and meta-regression.
    Pal R; Banerjee M; Prasad TN; Walia R; Bhadada T; Singh J; Bhadada SK
    J Bone Miner Res; 2024 Aug; 39(7):885-897. PubMed ID: 38703381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Body Composition in Patients With and Without Adrenal Tumors and Without Overt Hypersecretory Syndromes.
    Araujo-Castro M; Pascual-Corrales E; García Cano AM; Marchan M; Casals G; Hanzu FA; Gomez-Bermejo MÁ; Escobar Morreale HF; Valderrabano P
    Endocr Pract; 2023 Feb; 29(2):110-118. PubMed ID: 36455692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral steroid profiling of adrenal cortisol-producing adenomas by liquid chromatography- mass spectrometry.
    Teuber JP; Nanba K; Turcu AF; Chen X; Zhao L; Else T; Auchus RJ; Rainey WE; Rege J
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105924. PubMed ID: 34089832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
    Araujo-Castro M; Casals G; Hanzu FA; Pascual-Corrales E; García Cano AM; Lanza VF; Luis Del Rey Mejías Á; Marchan M; Escobar-Morreale HF; Valderrabano P
    Clin Endocrinol (Oxf); 2023 Feb; 98(2):165-176. PubMed ID: 35973974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel GC-MS/MS Technique Reveals a Complex Steroid Fingerprint of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3545-3556. PubMed ID: 30896752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients With Adrenal Incidentaloma.
    Moraes AB; de Paula MP; de Paula Paranhos-Neto F; Cavalari EMR; de Morais FFC; Curi DSC; Lima LFC; de Mendonça LMC; Farias MLF; Madeira M; Vieira Neto L
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
    Tauchmanovà L; Pivonello R; De Martino MC; Rusciano A; De Leo M; Ruosi C; Mainolfi C; Lombardi G; Salvatore M; Colao A
    Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression.
    Huayllas MKP; Smith LM; Gallagher JC; Netzel BC; Singh RJ; Kater CE
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):29-40. PubMed ID: 33598999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.